Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Munich - Delayed Quote EUR

Halozyme Therapeutics Inc (RV7.MU)

Compare
50.91
-3.83
(-7.00%)
As of 8:00:34 AM GMT+2. Market Open.
Loading Chart for RV7.MU
  • Previous Close 54.74
  • Open 50.91
  • Bid 51.18 x --
  • Ask 51.44 x --
  • Day's Range 50.91 - 50.91
  • 52 Week Range 35.14 - 60.22
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: RV7.MU

View More

Performance Overview: RV7.MU

Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

RV7.MU
12.31%
S&P 500 (^GSPC)
15.28%

1-Year Return

RV7.MU
39.17%
S&P 500 (^GSPC)
4.36%

3-Year Return

RV7.MU
32.68%
S&P 500 (^GSPC)
11.02%

5-Year Return

RV7.MU
212.33%
S&P 500 (^GSPC)
78.61%

Compare To: RV7.MU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RV7.MU

View More

Valuation Measures

Annual
As of 4/8/2025
  • Market Cap

    6.52B

  • Enterprise Value

    7.35B

  • Trailing P/E

    17.42

  • Forward P/E

    12.90

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.62

  • Price/Book (mrq)

    20.29

  • Enterprise Value/Revenue

    7.90

  • Enterprise Value/EBITDA

    12.22

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: RV7.MU

View More

Company Insights: RV7.MU

Research Reports: RV7.MU

View More